NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 8.15% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.23% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 7.15% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 7.03% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.98% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.91% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.81% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.81% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.81% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.76% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.55% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.51% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.44% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.00% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 2.21% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.08% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.88% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.61% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.56% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 1.53% |